News in the Life Sciences Industry

LUND, Sweden, Jan. 30, 2019 /PRNewswire/ -- BioInvent International AB (OMXS: BINV) announces today that the U.S. Food and Drug Administration (FDA) has granted the Company orphan designation for its proprietary antibody BI-1206 for the treatment of mantle cell lymphoma (MCL).... Read more ››

LUND, Sweden, Jan. 29, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), announces the publication of the results from a clinical phase I first-in-human study of the CD40 agonistic antibody ADC-1013 (JNJ-64457107). The top line data from this study was presented at... Read more ››

TORONTO, January 25, 2019 /PRNewswire/ --

Elekta's cutting-edge hardware and software innovations are transforming cancer therapy and ushering radiation therapy into the age of personalized precision medicine

STOCKHOLM, Jan. 25, 2019 /PRNewswire/ --Cantargia AB (publ) today announce that the first patient in the phase IIa part of the CANFOUR clinical trial has received CAN04 (nidanilimab) treatment in accordance with the clinical protocol. The CANFOUR trial investigates the antibody CAN04 for... Read more ››

SHANGHAI, Jan. 23, 2019 /PRNewswire/ -- Led by the Shanghai Branch of PICC Health Insurance Co., Ltd. (PICC) and the Shanghai MediTrust Health Co., Ltd. as well as supported by Pfizer China, the "Bo'ai Xin'an - Patient Benefit Management Program for breast cancer patients" (hereinafter referred... Read more ››

SINGAPORE, Jan. 22, 2019 /PRNewswire/ -- Mundipharma will be introducing BETADINE(TM) Cold Defence, a new early treatment hailed as a "world-first" ([i]), in the Middle East and Africa to help families stay healthy and fight the common cold.